The Assessment of Infection Risk in Patients with Vitiligo Undergoing Dialysis for End-Stage Renal Disease: A Retrospective Cohort Study
Pathogens · 2024
DOI: 10.3390/pathogens13010094 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pathogens, 2024. Verfasst von Pearl Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: Vitiligo, Kidney Failure, Chronic, Renal Dialysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, VA Research Career Scientist Award.
Abstract (Originalsprache)
Vitiligo is an autoimmune condition that causes patchy skin depigmentation. Although the mechanism by which vitiligo induces immunocompromise is unclear, other related autoimmune diseases are known to predispose those affected to infection. Individuals with vitiligo exhibit epidermal barrier disruption, which could potentially increase their susceptibility to systemic infections; patients with renal disease also show a predisposition to infection. Nevertheless, there is little research addressing the risk of infection in dialysis patients with vitiligo in comparison to those without it. A retrospective analysis was performed on patients with end-stage renal disease (ESRD) in the United States Renal Data System who started dialysis between 2004 and 2019 to determine if ESRD patients with vitiligo are at an increased risk of bacteremia, cellulitis, conjunctivitis, herpes zoster, or septicemia. Multivariable logistic regression modeling indicated that female sex, black compared to white race, Hispanic ethnicity, hepatitis C infection, and tobacco use were associated with an enhanced risk of vitiligo, whereas increasing age and catheter, versus arteriovenous fistula, and access type were associated with a decreased risk. After controlling for demographics and clinical covariates, vitiligo was found to be significantly associated with an increased risk of bacteremia, cellulitis, and herpes zoster but not with conjunctivitis and septicemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- Division of Biostatistics and Data Science, Department of Population Health Sciences, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- Charlie Norwood VA Medical Center, Augusta, GA 30904, USA.
- Department of Dermatology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- Department of Physiology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
ORCID-Profile: Mitchell Hanson, Jennifer L Waller, Wendy B Bollag
Förderung
- BLRD VA
- VA Research Career Scientist Award
Zitieren
APA
Shah, P., Hanson, M., Waller, J. L., Tran, S., Baer, S. L., Taskar, V., & Bollag, W. B. (2024). The Assessment of Infection Risk in Patients with Vitiligo Undergoing Dialysis for End-Stage Renal Disease: A Retrospective Cohort Study. Pathogens. https://doi.org/10.3390/pathogens13010094
Vancouver
Shah P, Hanson M, Waller JL, Tran S, Baer SL, Taskar V, et al. The Assessment of Infection Risk in Patients with Vitiligo Undergoing Dialysis for End-Stage Renal Disease: A Retrospective Cohort Study. Pathogens. 2024. doi:10.3390/pathogens13010094
BibTeX
@article{Shah2024,
author = {Shah, Pearl and Hanson, Mitchell and Waller, Jennifer L and Tran, Sarah and Baer, Stephanie L and Taskar, Varsha and Bollag, Wendy B},
title = {The Assessment of Infection Risk in Patients with Vitiligo Undergoing Dialysis for End-Stage Renal Disease: A Retrospective Cohort Study},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13010094}
}
EUVIMED